Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers. |
Retention & Performance Awards
On September 30, 2024, the Compensation & Human Capital Committee of the Board of Directors (the Committee) of Endo,
Inc. (the Company) approved retention and performance awards (the Awards) for certain senior officers and employees of the Company, including Matthew J. Maletta, Executive Vice President, Chief Legal Officer and Secretary,
Mark Bradley, Executive Vice President and Chief Financial Officer, Patrick Barry, Executive Vice President and President, Global Commercial Operations, and James Tursi, M.D., Executive Vice President and President, Global Research and Development
(collectively, the Participants). The Awards provide the Participants the opportunity to receive future cash payments, subject to satisfying the below-described performance-based and time-based vesting conditions. The form of the Awards
is attached as Exhibit 10.1 hereto.
The Awards are scheduled to vest on September 30, 2025 (the Vesting Date), subject
to specific performance-based and time-based conditions. The vesting of seventy percent (70%) of each Award (the Performance-Based Component) is conditioned on both (i) the Participant remaining employed by the Company until the
Vesting Date and (ii) the Companys achievement of certain pre-established financial targets (the Performance Targets), as measured for the year ended December 31, 2024. The vesting
of thirty percent (30%) of each Award (the Time-Based Component) is conditioned on the Participant remaining employed by the Company until the Vesting Date. If a Participant voluntarily resigns or is terminated by the Company for cause prior
to the Vesting Date, their Award will be forfeited in its entirety. If a Participant is terminated by the Company without cause prior to the Vesting Date, (i) the Time-Based Components vesting will accelerate and payment will occur as
soon as practicable following the termination, and (ii) the Performance-Based Components vesting will remain subject to the achievement of the Performance Targets and any payment(s) will not occur until after the Vesting Date.
The total amounts potentially payable pursuant to the Awards are as follows: (i) $514,830 for Mr. Maletta, (ii) $507,259 for
Mr. Bradley, (iii) $476,974 for Mr. Barry, (iv) $403,650 for Dr. Tursi and (v) an aggregate of approximately $1,200,000 for the remaining Participants. The Awards are in addition to awards made under other incentive plans in
which the Participants participate, including annual cash incentive awards and long-term equity awards. The Companys Interim Chief Executive Officer, Scott Hirsch, did not receive an Award.
2024 Stock Incentive Plan Award Notices
Additionally, on September 30, 2024, the Committee approved the Form of Employee RSU Award Notice, Form of Director RSU Award Notice and
Form of Employee PSU Award Notice, each under the Companys 2024 Stock Incentive Plan. The form stock incentive plan award notices are attached hereto as Exhibits 10.2, 10.3 and 10.4, respectively.
Item 9.01. |
Financial Statements and Exhibits. |
(d) Exhibits.
|
|
|
Number |
|
Description |
|
|
10.1 |
|
Form of 2024 Retention and Performance Award Notice. |
|
|
10.2 |
|
Form of Employee RSU Award Notice under Endo, Inc.s 2024 Stock Incentive Plan. |
|
|
10.3 |
|
Form of Director RSU Award Notice under Endo, Inc.s 2024 Stock Incentive Plan. |
|
|
10.4 |
|
Form of Employee PSU Award Notice under Endo, Inc.s 2024 Stock Incentive Plan. |
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |